Literature DB >> 8420823

Insulin secretory function in relation to transplanted islet mass in STZ-induced diabetic rats.

B W Tobin1, J T Lewis, D Z Chen, D T Finegood.   

Abstract

In vivo insulin secretion was quantified as the AIRg or AIRa in islet-transplanted rats. Male Wistar-Furth rats previously made diabetic by STZ administration (55 mg/kg) were transplanted with 500, 1000, 2000, or 3000 islets infused into the portal vein (n = 12-14 per group) and were compared with sham-treated controls (CN, n = 16). At 4-5 wk posttransplantation, no significant differences were noted in the FPG or fasting plasma insulin of the experimental groups (P > 0.05). Body weight, however, was 10% less (P < 0.05) in rats receiving 500 islets than in controls, indicating an effect of beta-cell deficiency on growth rates. To determine the relationship between islet mass and insulin secretion, we measured AIRg after a 0.3 g/kg glucose bolus in fasted conscious animals. A significant correlation was observed between the AIRg and islet number (r = 0.61, P = 0.0001), and both 500- and 1000-islet groups could be differentiated from controls by ANOVA (500: 8%; 1000: 12% of controls; P < 0.05). During a glycemic potentiation protocol, AIRa was measured at basal and elevated blood glucose (approximately 16 mM). At neither basal nor elevated blood glucose was AIRa correlated with islet number (basal r = 0.0622, P = 0.7834; elevated r = 0.3133, P = 0.1667). None of the groups could be differentiated by ANOVA (elevated 500: 37%; 1000, 68% of controls; P > 0.05). Although this study illustrates that AIRa may be better preserved in islet-transplanted rats, AIRg is the better correlate of islet number.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420823     DOI: 10.2337/diab.42.1.98

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Early metabolic markers that anticipate loss of insulin independence in type 1 diabetic islet allograft recipients.

Authors:  D Hirsch; J Odorico; J S Danobeitia; R Alejandro; M R Rickels; M Hanson; N Radke; D Baidal; D Hullett; A Naji; C Ricordi; D Kaufman; L Fernandez
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  Arginine is preferred to glucagon for stimulation testing of β-cell function.

Authors:  R Paul Robertson; Ralph H Raymond; Douglas S Lee; Roberto A Calle; Atalanta Ghosh; Peter J Savage; Sudha S Shankar; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

3.  Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass.

Authors:  E Montaña; S Bonner-Weir; G C Weir
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Islet transplantation reverses carcass protein loss in diabetic rats without inducing disproportionate fat accumulation.

Authors:  B W Tobin; M J Marchello
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

5.  Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia.

Authors:  Matthew A Smith; Marisa D Covington; Rick G Schnellmann
Journal:  Arch Biochem Biophys       Date:  2012-05-01       Impact factor: 4.013

6.  Assessment of β-cell mass and α- and β-cell survival and function by arginine stimulation in human autologous islet recipients.

Authors:  R Paul Robertson; Lindsey D Bogachus; Elizabeth Oseid; Susan Parazzoli; Mary Elizabeth Patti; Michael R Rickels; Christian Schuetz; Ty Dunn; Timothy Pruett; A N Balamurugan; David E R Sutherland; Gregory Beilman; Melena D Bellin
Journal:  Diabetes       Date:  2014-09-03       Impact factor: 9.461

7.  Functional assessment of pancreatic beta-cell area in humans.

Authors:  Juris J Meier; Bjoern A Menge; Thomas G K Breuer; Christophe A Müller; Andrea Tannapfel; Waldemar Uhl; Wolfgang E Schmidt; Henning Schrader
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.